A biopharmaceutical company developing antibody radionuclide conjugates for haematological cancers with their lead molecule Betalutin in Phase I and IIb studies.

Location

Grafenauweg 10, 6300 Zug, Switzerland

Facts & figures
  • Type of organization

    Public company

  • Year of foundation

    2009

  • Number of employees in Switzerland

    1-9

Key business